Additionally, enhancing the expression of MHC II on antigen-presenting cells (APCs) can enhance the helper function of CD4+ T cells, which is crucial for maintaining an effective anti-tumor immune response and improving the success rate of vaccines and immune checkpoint blockade therapies. The gene discussed is CD4; the disease is neoplasm.